Heba Effat
Cairo, C 11796, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Synergistic effects of sorafenib and cilostazol in HepG2 cells.
Journal: Journal of biosciences
Published: September 02, 2026
Isatin-mediated inhibition of the PI3K/AKT/EMT signaling axis confers antitumor efficacy in Ehrlich solid carcinoma-bearing mice.
Journal: BMC cancer
Published: February 17, 2026
Correction: The Combined Impact of Curcumin: Piperine and Sorafenib on microRNAs and Different Pathways in Breast Cancer Cells.
Journal: Indian journal of clinical biochemistry : IJCB
Published: February 12, 2026
Isatin, a monoamine oxidase inhibitor, sensitizes resistant breast cancer cells to tamoxifen via MAO-A/HIF1α/MMPs modulation.
Journal: RSC medicinal chemistry
Published: August 03, 2025
Cyclophosphamide: Potential Hepatorenal Toxicity and the Possible Therapeutic Role of Mesenchymal Stem Cell-Derived Exosomes in Wistar Rats.
Journal: Journal of biochemical and molecular toxicology
Published: December 26, 2024
Vitamin D promotes anticancer effects of low-concentration cisplatin-treated non-small cell lung cancer cells via inhibiting the JAK2/STAT3 and TGF-β/SMAD4 pathways.
Journal: Archiv der Pharmazie
Published: December 10, 2024
Rutin Alleviates Breast Cancer Resistance to Tamoxifen By Downregulating ABC Transporters, Inducing ROS Generation and Resetting Redox Status.
Journal: Journal of biochemical and molecular toxicology
Published: October 19, 2024
Effect of palliative radiotherapy and cyclin-dependent kinase 4/6 inhibitor on breast cancer cell lines.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 30, 2024
The clinical potential of PDL-1 pathway and some related micro-RNAs as promising diagnostic markers for breast cancer.
Journal: Molecular medicine (Cambridge, Mass.)
Published: July 31, 2024
Anti-Proliferative and Apoptotic Evaluation of a Novel Synthesized Acridine Hybrid With Anticipated Synergistic Effect to Paclitaxel on Breast Cancer Cells.
Journal: Chemical biology & drug design
Published: July 07, 2024
Author Correction: Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel‑related ovarian damage in mice.
Journal: Scientific reports
Published: April 29, 2024
Primary Protection of Diosmin Against Doxorubicin Cardiotoxicity via Inhibiting Oxido-Inflammatory Stress and Apoptosis in Rats.
Journal: Cell biochemistry and biophysics
Published: April 19, 2024
Last Updated: 09/26/2026